BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38368603)

  • 61. Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD.
    Blum WF; Bright GM; Do MT; McKew JC; Chen H; Thorner MO
    J Endocr Soc; 2021 Jun; 5(6):bvab029. PubMed ID: 33982678
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 63. Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial.
    Dombernowsky SL; Damholt BB; Højby Rasmussen M; Sværke C; Kildemoes RJ
    Clin Pharmacokinet; 2024 Jul; ():. PubMed ID: 38969919
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic Changes across Tertiles of Delta Changes in Height SDS during Growth Hormone Therapy in Children with Growth Hormone Deficiency.
    Giannini C; Mastromauro C; Polidori N; Chiarelli F; Mohn A
    Horm Res Paediatr; 2022; 95(5):415-422. PubMed ID: 35772388
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study.
    Owada Y; Okazaki M; Ikeda T; Yamamoto R; Minami K; Takahashi K; Hirato T; Mita Y; Yamamoto T; Tanizawa K; Sonoda H; Sato Y
    Growth Horm IGF Res; 2022 Dec; 67():101500. PubMed ID: 36113378
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study.
    Abe I; Takeshita K; Nagata M; Fujita Y; Ochi K; Koga M; Kudo T; Shimada H; Abe M; Mukoubara S; Kobayashi K
    Medicine (Baltimore); 2023 Sep; 102(38):e34730. PubMed ID: 37746989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us?
    Plachy L; Amaratunga SA; Dusatkova P; Maratova K; Neuman V; Petruzelkova L; Zemkova D; Obermannova B; Snajderova M; Kolouskova S; Sumnik Z; Lebl J; Pruhova S
    Front Endocrinol (Lausanne); 2022; 13():1102968. PubMed ID: 36714562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database.
    Fujieda K; Tanaka T; Takano K; Chihara K; Seino Y; Irie M;
    J Pediatr Endocrinol Metab; 2011; 24(7-8):457-62. PubMed ID: 21932582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
    Biller BM; Ji HJ; Ahn H; Savoy C; Siepl EC; Popovic V; Coculescu M; Roemmler J; Gavrila C; Cook DM; Strasburger CJ
    Pituitary; 2013 Sep; 16(3):311-8. PubMed ID: 22915288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
    Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C
    Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Different long-term response to growth hormone therapy in small- versus appropriate-for-gestational-age children with growth hormone deficiency.
    Meazza C; Pagani S; Pietra B; Tinelli C; Calcaterra V; Bozzola E; Bozzola M
    Horm Res Paediatr; 2013; 79(4):214-9. PubMed ID: 23635718
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Gomez R; Khadilkar V; Shembalkar J; Chu DM; Ko CW; Wajnrajch MP; Wang R
    J Pediatr Endocrinol Metab; 2024 Jun; 37(6):525-531. PubMed ID: 38717038
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and Insulin-like Growth Factor-I Z-scores.
    Oberle M; Grimberg A; Bamba V
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):208-215. PubMed ID: 28150584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
    Du H; Wu D; Yi P; Bai X; Luo Y; Yang H; Chen S; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):511-517. PubMed ID: 35245011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis.
    Mameli C; Orso M; Calcaterra V; Wasniewska MG; Aversa T; Granato S; Bruschini P; Guadagni L; d'Angela D; Spandonaro F; Polistena B; Zuccotti G
    Pharmacol Res; 2023 Jul; 193():106805. PubMed ID: 37236413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.